ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,267Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 463

$579K Total Retail Price of All Prescriptions

Rank: 61 out of 463

227 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 227 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 10,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $131 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
WARFARIN SODIUM 576 576 1 70
FUROSEMIDE 499 499 2 25
OMEPRAZOLE 412 412 3 27
LEVOTHYROXINE SODIUM 398 398 4 1
SIMVASTATIN 351 351 5 7
DONEPEZIL HCL 295 295 6 79
NAMENDA 237 237 7 112
LISINOPRIL 234 234 8 15
METOPROLOL TARTRATE 217 217 9 31
GABAPENTIN 201 201 10 48
AMLODIPINE BESYLATE 191 191 11 12
ALBUTEROL SULFATE 187 187 12 164
MIRTAZAPINE 179 179 13 116
TRAZODONE HCL 139 139 14 155
PREDNISONE 136 136 15 161
CITALOPRAM HBR 136 136 15 94
DIVALPROEX SODIUM 132 132 17 185
TRAMADOL HCL 130 130 18 85
ATENOLOL 125 125 19 29
CARVEDILOL 121 121 20 47
POTASSIUM CHLORIDE 118 118 21 76
DIGOXIN 103 103 22 169
FLUOCINONIDE 100 100 23 147
LEVOFLOXACIN 98 98 24 166
TAMSULOSIN HCL 94 88 25 67
SERTRALINE HCL 91 86 26 90
DIOVAN 89 89 27 42
LIDODERM 88 88 28 80
METOPROLOL SUCCINATE 85 85 29 28
ATORVASTATIN CALCIUM 83 72 30 10
IPRATROPIUM BROMIDE 80 80 31 219
LANTUS 78 78 32 16
ESCITALOPRAM OXALATE 73 73 33 103
NOVOLIN R 70 70 34 162
RAMIPRIL 69 69 35 45
METFORMIN HCL 63 63 36 3
LATANOPROST 59 59 37 201
PANTOPRAZOLE SODIUM 58 58 38 105
ISOSORBIDE MONONITRATE ER 58 58 38 105
RISPERIDONE 57 57 40 199
CARBIDOPA-LEVODOPA 56 56 41 250
FAMOTIDINE 56 56 41 110
MUPIROCIN 53 53 43 259
ALLOPURINOL 53 53 43 74
SPIRIVA 51 51 45 167
SANTYL 50 50 46 265
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.